In the carcinogenic process, promotion is the process whereby an initiated tissue develops focal proliferations which act as proximate precursors. The evidence obtained from the immunocytochemical staining by monoclonal anti-receptor antibodies indicates that the early steps (atypical hyperplasias) in the carcinogenic process of the breast show an increased and homogeneous expression of the estrogen receptor. These observations suggest that the persistent sensitivity to estrogen may be critical in sustaining the growth of mammary preneoplastic changes and their progression to ultimate precursors and to invasive cancer. © 1988.

Commentary on human mammary neoplasia. The Estrogen Receptor-promotion hypothesis

NENCI, Italo;MARCHETTI, Elisabetta;QUERZOLI, Patrizia
1988

Abstract

In the carcinogenic process, promotion is the process whereby an initiated tissue develops focal proliferations which act as proximate precursors. The evidence obtained from the immunocytochemical staining by monoclonal anti-receptor antibodies indicates that the early steps (atypical hyperplasias) in the carcinogenic process of the breast show an increased and homogeneous expression of the estrogen receptor. These observations suggest that the persistent sensitivity to estrogen may be critical in sustaining the growth of mammary preneoplastic changes and their progression to ultimate precursors and to invasive cancer. © 1988.
1988
Nenci, Italo; Marchetti, Elisabetta; Querzoli, Patrizia
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/1739065
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 32
social impact